Experimental Andes Virus Infection in Deer Mice: Characteristics of Infection and Clearance in a Heterologous Rodent Host

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Spengler, Jessica R ^a,b   Haddock, Elaine ^a   Gardner, Don ^a   Hjelle, Brian ^c   Feldmann, Heinz ^a   Prescott, Joseph ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 23; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NEUTRALIZING ANTIBODY; RANTES; TRANSFORMING GROWTH FACTOR BETA; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS RNA;

ADAPTATION; ANDES VIRUS; ANDES VIRUS INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; ASYMPTOMATIC INFECTION; BLOOD; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FEMALE; GENE IDENTIFICATION; HANTAVIRUS; HANTAVIRUS INFECTION; HEART; HISTOPATHOLOGY; HOST; HUMORAL IMMUNITY; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; LUNG; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PEROMYSCUS; PERSISTENT INFECTION; SIN NOMBRE VIRUS; SPLEEN; SYMPTOM; UPREGULATION; VIRAL CLEARANCE; VIRUS CARRIER; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; ARVICOLINAE; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES; DISEASE RESERVOIRS; DISEASE VECTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HANTAVIRUS; HANTAVIRUS INFECTIONS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NEUTRALIZATION TESTS; PEROMYSCUS; RATS; REAL-TIME POLYMERASE CHAIN REACTION; SOUTH AMERICA; VIRUS REPLICATION;

EID: 84873167192     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055310     Document Type: Article

References (52)

1. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, et al. (1993) Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262: 914-917.
2. Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, et al. (1995) Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 146: 552-579.
3. Hjelle B, (2002) Vaccines against hantaviruses. Expert Rev Vaccines 1: 373-384.
4. Hooper JW, Li D, (2001) Vaccines against hantaviruses. Curr Top Microbiol Immunol 256: 171-191.
5. Enria DA, Pinheiro F, (2000) Rodent-borne emerging viral zoonosis. Hemorrhagic fevers and hantavirus infections in South America. Infect Dis Clin North Am 14: 167-184, x.
6. Rand MS, (1994) Hantavirus: an overview and update. Lab Anim Sci 44: 301-304.
7. Bi Z, Formenty PB, Roth CE, (2008) Hantavirus infection: a review and global update. J Infect Dev Ctries 2: 3-23.
8. Childs JE, Glass GE, Ksiazek TG, Rossi CA, Oro JG, et al. (1991) Human-rodent contact and infection with lymphocytic choriomeningitis and Seoul viruses in an inner-city population. Am J Trop Med Hyg 44: 117-121.
9. Warner GS, (1996) Hantavirus illness in humans: review and update. South Med J 89: 264-271.
10. Mills JN, Childs JE, (1998) Ecologic studies of rodent reservoirs: their relevance for human health. Emerg Infect Dis 4: 529-537.
11. Klingstrom J, Heyman P, Escutenaire S, Sjolander KB, De Jaegere F, et al. (2002) Rodent host specificity of European hantaviruses: evidence of Puumala virus interspecific spillover. J Med Virol 68: 581-588.
12. Plyusnin A, Morzunov SP, (2001) Virus evolution and genetic diversity of hantaviruses and their rodent hosts. Curr Top Microbiol Immunol 256: 47-75.
13. Ramsden C, Holmes EC, Charleston MA, (2009) Hantavirus evolution in relation to its rodent and insectivore hosts: no evidence for codivergence. Molecular biology and evolution 26: 143-153.
14. Calisher CH, Sweeney W, Mills JN, Beaty BJ, (1999) Natural history of Sin Nombre virus in western Colorado. Emerging infectious diseases 5: 126-134.
15. Safronetz D, Zivcec M, Lacasse R, Feldmann F, Rosenke R, et al. (2011) Pathogenesis and host response in Syrian hamsters following intranasal infection with Andes virus. PLoS Pathog 7: e1002426.
16. Geimonen E, Neff S, Raymond T, Kocer SS, Gavrilovskaya IN, et al. (2002) Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci U S A 99: 13837-13842.
17. Sadeghi M, Eckerle I, Daniel V, Burkhardt U, Opelz G, et al. (2011) Cytokine expression during early and late phase of acute Puumala hantavirus infection. BMC Immunol 12: 65.
18. Schountz T, Prescott J, Cogswell AC, Oko L, Mirowsky-Garcia K, et al. (2007) Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus. Proc Natl Acad Sci U S A 104: 15496-15501.
19. Botten J, Mirowsky K, Kusewitt D, Ye C, Gottlieb K, et al. (2003) Persistent Sin Nombre virus infection in the deer mouse (Peromyscus maniculatus) model: sites of replication and strand-specific expression. J Virol 77: 1540-1550.
20. Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, et al. (1994) Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. The New England journal of medicine 330: 949-955.
21. Botten J, Ricci R, Hjelle B, (2001) Establishment of a deer mouse (Peromyscus maniculatus rufinus) breeding colony from wild-caught founders: comparison of reproductive performance of wild-caught and laboratory-reared pairs. Comp Med 51: 314-318.
22. Meissner JD, Rowe JE, Borucki MK, St Jeor SC, (2002) Complete nucleotide sequence of a Chilean hantavirus. Virus Res 89: 131-143.
23. Taylor RT, Lubick KJ, Robertson SJ, Broughton JP, Bloom ME, et al. (2011) TRIM79alpha, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase. Cell Host Microbe 10: 185-196.
24. Safronetz D, Hegde NR, Ebihara H, Denton M, Kobinger GP, et al. (2009) Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus. Journal of virology 83: 7285-7295.
25. Schountz T, Acuna-Retamar M, Feinstein S, Prescott J, Torres-Perez F, et al. (2012) Kinetics of immune responses in deer mice experimentally infected with Sin Nombre virus. Journal of virology 86: 10015-10027.
26. Mills JN YT, Childs JE, Parmenter RR, Ksiazek TG, Rollin PE, et al. (1995) Guidelines for working with rodents potentially infected with hantavirus. Journal of Mammalogy 76: 716-722.
27. Botten J, Mirowsky K, Kusewitt D, Bharadwaj M, Yee J, et al. (2000) Experimental infection model for Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus). Proc Natl Acad Sci U S A 97: 10578-10583.
28. Zhang XK, Takashima I, Hashimoto N, (1989) Characteristics of passive immunity against hantavirus infection in rats. Arch Virol 105: 235-246.
29. Dantas JR Jr, Okuno Y, Asada H, Tamura M, Takahashi M, et al. (1986) Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies. Virology 151: 379-384.
30. Arikawa J, Schmaljohn AL, Dalrymple JM, Schmaljohn CS, (1989) Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J Gen Virol 70 (Pt 3) (): 615-624.
31. Arikawa J, Yao JS, Yoshimatsu K, Takashima I, Hashimoto N, (1992) Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies. Arch Virol 126: 271-281.
32. Schmaljohn CS, Chu YK, Schmaljohn AL, Dalrymple JM, (1990) Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J Virol 64: 3162-3170.
33. Lundkvist A, Niklasson B, (1992) Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins: identification of epitopes involved in neutralization. Arch Virol 126: 93-105.
34. Brown KS, Safronetz D, Marzi A, Ebihara H, Feldmann H, (2011) Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus. Journal of virology 85: 12781-12791.
35. Ray N, Whidby J, Stewart S, Hooper JW, Bertolotti-Ciarlet A, (2010) Study of Andes virus entry and neutralization using a pseudovirion system. Journal of virological methods 163: 416-423.
36. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A, (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765.
37. Raport CJ, Gosling J, Schweickart VL, Gray PW, Charo IF, (1996) Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J Biol Chem 271: 17161-17166.
38. Blanpain C, Migeotte I, Lee B, Vakili J, Doranz BJ, et al. (1999) CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood 94: 1899-1905.
39. Combadiere C, Ahuja SK, Tiffany HL, Murphy PM, (1996) Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1(alpha), MIP-1(beta), and RANTES. J Leukoc Biol 60: 147-152.
40. Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M, (1996) Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35: 3362-3367.
41. Gavrilovskaya IN, Shepley M, Shaw R, Ginsberg MH, Mackow ER, (1998) beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci U S A 95: 7074-7079.
42. Easterbrook JD, Klein SL, (2008) Corticosteroids modulate Seoul virus infection, regulatory T-cell responses and matrix metalloprotease 9 expression in male, but not female, Norway rats. The Journal of general virology 89: 2723-2730.
43. Viral Special Pathogens Branch, CDC (2012) Hantavirus Technical/Clinical Information, Diagnostics. Available: http://www.cdc.gov/hantavirus/technical/hps/diagnostics.html. Last Accessed 3 January 2012.
44. Saksida A, Duh D, Korva M, Avsic-Zupanc T, (2008) Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J Infect Dis 197: 681-685.
45. Xiao R, Yang S, Koster F, Ye C, Stidley C, et al. (2006) Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J Infect Dis 194: 1403-1409.
46. Yaeger MJ, (2002) The diagnostic sensitivity of immunohistochemistry for the detection of porcine reproductive and respiratory syndrome virus in the lung of vaccinated and unvaccinated swine. J Vet Diagn Invest 14: 15-19.
47. Levine JR, Prescott J, Brown KS, Best SM, Ebihara H, et al. (2010) Antagonism of type I interferon responses by new world hantaviruses. J Virol 84: 11790-11801.
48. Spiropoulou CF, Albarino CG, Ksiazek TG, Rollin PE, (2007) Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J Virol 81: 2769-2776.
49. Alff PJ, Gavrilovskaya IN, Gorbunova E, Endriss K, Chong Y, et al. (2006) The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol 80: 9676-9686.
50. Alff PJ, Sen N, Gorbunova E, Gavrilovskaya IN, Mackow ER, (2008) The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation. J Virol 82: 9115-9122.
51. Staudinger R, Phogat SK, Xiao X, Wang X, Dimitrov DS, et al. (2003) Evidence for CD4-enchanced signaling through the chemokine receptor CCR5. J Biol Chem 278: 10389-10392.
52. Wang X, Staudinger R, (2003) Interaction of soluble CD4 with the chemokine receptor CCR5. Biochem Biophys Res Commun 307: 1066-1069.